91AV

Molecular Omics invites original research and review papers on the latest advances in lipidomics.

Lipidomics is a growing field in the -omics space, bringing together the advances in analytical solutions with bioinformatics to support evolution in the comprehensive study of lipids within biological systems. The advances in lipidomics offer unparalleled insights into the diverse roles lipids play in health and disease, holding immense promise for biomarker discovery and the early detection, prognosis, and monitoring of various diseases, including metabolic disorders, cancer and neurodegenerative diseases. Additionally, lipidomics approaches are revolutionizing drug discovery by identifying lipid-based therapeutic targets and assessing drug efficacy and safety.

Beyond health, lipidomics extends its reach into food and nutrition science, shedding light on the impact of dietary lipids on human health and disease prevention. Moreover, lipidomics is increasingly being applied in marine and environmental studies, offering valuable insights in ecosystem health, pollutant monitoring, and climate change scenarios. In essence, lipidomics is not just a scientific endeavour but a tool for societal change, addressing pressing challenges such as public health and environmental sustainability through its multifaceted applications and analytical prowess.

This collection will present the most recent advances in lipidomics, from analytical advances to innovative solutions addressing societal challenges, across diseases, to food, microbiome and environmental fields.

Manuscripts should be submitted via the journal’s and the Editorial Office informed by email. Please add a “note to the editor” in the submission form when you submit your manuscript to indicate that this is a submission for the themed collection. The Editorial Office reserves the right to check the suitability of submissions in relation to the scope of the collection and inclusion of accepted articles in the collection is not guaranteed.

All manuscripts will be subject to the journal's usual peer review process. Accepted manuscripts will be highlighted together in a dedicated web collection alongside an editorial, regardless of submission date, and there will be no delay in the publication of all accepted manuscripts into regular issues of Molecular Omics.

Molecular Omics is a Transformative Journal, and Plan S compliant

This collection in RSC Chemical Biology and RSC Pharmaceutics will explore how both biological and synthetic tools can be leveraged to understand the impact of material structure on the migration of specific cellular barriers, aiming to enhance the delivery efficiency of macromolecules and delivery systems such as liposomes, lipid nanoparticles, and polymeric carriers. Key topics will include the following:

1. Novel tools to understand and quantify cellular trafficking of nanoparticles and their cargo, including processes such as endosomal escape, membrane fusion, cytosolic delivery and nuclear localisation.
2. Fundamental understanding of how nanoparticle structure impacts cellular interactions.
3. Design of new delivery systems that incorporate intelligent strategies to migrate biological barriers for more effective therapeutic delivery.
4. Novel tools, methodologies to understand and quantify cell uptake and the fate of the multiple components in drug delivery systems.
5. Tools/basic understanding on the role of the protein corona on the fate of the particles beyond the very general basic level

Ideally, computational work should be experimentally validated wherever possible. For articles to be accepted into the collection, the applications and relevance to chemical biology must be clear.

Authors are welcome to submit original research in the form of a Communication or Full Paper. The manuscript should be prepared according to our article guidelines and submitted via the respective journal’s website, or . Information on the journals’ scopes can be found at the bottom of this page.

All manuscripts will be subject to the usual initial assessment and peer review processes as necessary, and inclusion in the Collection will be at the discretion of the Guest Editors. Please indicate in your submission that you are submitting to this Collection and inform the Editorial Office by email.

Following our peer-review process, we will publish accepted articles online in a citeable form as soon as they are ready, with compilation and promotion of the complete collection in mid 2025.

About RSC Chemical Biology

Led by Hiroaki Suga (University of Tokyo), RSC Chemical Biology is dedicated to publishing and disseminating the most exceptionally significant, breakthrough findings of interest to the chemical biology community. All submissions are handled by our experienced and internationally recognised Associate Editors. For more information on the journal, please visit the .

About RSC Pharmaceutics

RSC Pharmaceutics acknowledges how chemistry and related disciplines can make a big difference to addressing health challenges. The journal provides a platform to publish crucial research on pharmaceutics, covering emerging technologies and techniques in pharmaceutics, including drug delivery, precision medicine, and enhanced drug targeting. Publications in RSC Pharmaceutics have the potential to drive real change in worldwide health. For more information on the journal, please visit the .

As gold open access journals, there are no barriers to accessing content and your research article will reach an international audience. Article processing charges apply at RSC Chemical Biology – please see the journal web site for details on fees, discounts, and waivers.

Glycans have come a long way from their consideration of “decorating” biomolecules to proven, essential modulators of physiology. 91AV has played an essential part in this process: the non-templated biosynthesis of glycans needed tools for their profiling, perturbation and visualization. The field of glycobiology has thus served as a catalyst to invent new chemistry, recognized through awards by major learned societies as well as the Nobel Prize in 91AV in 2022.

Through the invention of new tools, their use in understanding critical new biology, and their application in quantitative biology, it is certain that today, chemical glycobiology is advancing the boundaries of science. This themed collection seeks to highlight the use of innovative chemistry in advancing glycobiology in its full breadth. We are excited about contributions that feature all aspects of a field that truly tackles the sweet side of biology!

Authors are welcome to submit original research in the form of a Communication or Full Paper. The manuscript should be prepared according to our article guidelines and submitted via our online system. Ideally, computational work should be experimentally validated wherever possible. For articles to be accepted into the collection, the applications and relevance to chemical biology must be clear. For more information on the journal, please see the foot of this message or visit the journal homepage.

All manuscripts will be subject to the usual initial assessment and peer review processes as necessary, and inclusion in the Collection will be at the discretion of the Guest Editors. Please indicate in your submission that you are submitting to this Collection and inform the Editorial Office by email.

Following our peer-review process, we will publish accepted articles online in a citeable form as soon as they are ready, with compilation and promotion of the complete collection in late 2025.

About RSC Chemical Biology

Led by Hiroaki Suga (University of Tokyo), RSC Chemical Biology is dedicated to publishing and disseminating the most exceptionally significant, breakthrough findings of interest to the chemical biology community. All submissions are handled by our experienced and internationally recognised Associate Editors. For more information on the journal, please visit the .

As gold open access journals, there are no barriers to accessing content and your research article will reach an international audience. Article processing charges apply - please see the journal web site for details on fees, discounts, and waivers.

This themed collection will highlight the latest advances in induced-proximity pharmacology, covering the following topics:

• Medicinal chemistry design and optimization of molecular glue and heterobifunctional degraders (e.g. PROTACs)
• Medicinal chemistry of induced-proximity pharmacology beyond targeted protein degradation
• Structure-activity/property/toxicity relationships that provide general learning for medicinal chemists working in the field of induced-proximity
• Development of novel protein ligands (including peptides or oligonucleotides) to enable the design of molecules that induce biomolecule proximity
• Design and development of RNA modulators using induced-proximity approaches
• Application of in silico empowered or miniaturized/automated approaches to streamline the identification or optimization of proximity-inducing drug candidates
• Medicinal chemistry of biotherapeutics that possess an induced-proximity mode of action
• Elucidation of molecular mechanisms of induced-proximity pharmacology using chemical techniques that aid drug development

Manuscripts should be submitted via the journal’s and the Editorial Office informed by email. Please add a “note to the editor” in the submission form when you submit your manuscript to indicate that this is a submission for the themed collection. The Editorial Office reserves the right to check the suitability of submissions in relation to the scope of the collection and inclusion of accepted articles in the collection is not guaranteed.

All manuscripts will be subject to the journal's usual peer review process. Accepted manuscripts will be highlighted together in a dedicated web collection alongside an editorial, regardless of submission date, and there will be no delay in the publication of all accepted manuscripts into regular issues of RSC Medicinal 91AV.

RSC Medicinal 91AV is a Transformative Journal and Plan S compliant

RSC Medicinal 91AV and Organic & Biomolecular 91AV invite original research and review papers on photoswitches and photopharmacology.

Molecular photoswitches are unique tools that allow us to selectively translate a benign and precise stimulus (light) into a change in molecular structure, thereby enabling the photocontrol of many key processes, most prominently those in biological systems. The research on molecular photoswitches encompasses many disciplines and research approaches, from physics and quantum mechanics, through chemistry and all the way to biology and medicine. We aim to represent this multidisciplinary and broad scope of photoswitch design and application in the web themed issue.

With this in mind, we welcome submissions on all topics pertaining to the development and characterization of molecular photoswitches, especially with the outlook on their biological and biomedical applications. The areas that are of special interest include (but are not limited to) the design, also computational, of (regular and visible-light-operated) photoswitches, their synthesis (including spectroscopic evaluation), applications in nanomedicine, photopharmacology, chemical biology, bio-sensing and imaging.

Manuscripts should be submitted via the journals’ online submission services, and , and the Editorial Office informed by email. Please add a “note to the editor” in the submission form when you submit your manuscript to indicate that this is a submission for the themed collection. The Editorial Office reserves the right to check the suitability of submissions in relation to the scope of the collection and inclusion of accepted articles in the collection is not guaranteed.

All manuscripts will be subject to the journal's usual peer review process. Accepted manuscripts will be highlighted together in a dedicated web collection alongside an editorial, regardless of submission date, and there will be no delay in the publication of all accepted manuscripts into regular issues of RSC Medicinal 91AV and Organic & Biomolecular 91AV.

RSC Medicinal 91AV is a Transformative Journal and Plan S compliant

This themed collection will highlight the latest advances in the field of kinases, covering the following topics:

• Medicinal chemistry design and optimization of novel kinase inhibitors
• Medicinal chemistry approaches beyond classic kinase orthosteric inhibitors, such as allosteric, covalent, molecular glues, degrader, peptide approaches
• Novel Mechanism of Action and new pharmacology associated with a particular kinase target
• Methods or examples of gaining exquisite selectivity for a known family of kinases
• Structural insights of new kinases and impact on drug design and/or hit generation
• Application of in silico approaches to streamline the identification or optimization of kinase drug candidates

Manuscripts should be submitted via the journal’s and the Editorial Office informed by email. Please add a “note to the editor” in the submission form when you submit your manuscript to indicate that this is an open call submission for the themed collection. The Editorial Office reserves the right to check the suitability of submissions in relation to the scope of the collection and inclusion of accepted articles in the collection is not guaranteed.

All manuscripts will be subject to the journal's usual peer review process. Accepted manuscripts will be highlighted together in a dedicated web collection alongside an editorial, regardless of submission date, and there will be no delay in the publication of all accepted manuscripts into regular issues of RSC Medicinal 91AV.

RSC Medicinal 91AV is a Transformative Journal and Plan S compliant

This collection in RSC Chemical Biology and RSC Pharmaceutics will explore how both biological and synthetic tools can be leveraged to understand the impact of material structure on the migration of specific cellular barriers, aiming to enhance the delivery efficiency of macromolecules and delivery systems such as liposomes, lipid nanoparticles, and polymeric carriers. Key topics will include the following:

1. Novel tools to understand and quantify cellular trafficking of nanoparticles and their cargo, including processes such as endosomal escape, membrane fusion, cytosolic delivery and nuclear localisation.
2. Fundamental understanding of how nanoparticle structure impacts cellular interactions.
3. Design of new delivery systems that incorporate intelligent strategies to migrate biological barriers for more effective therapeutic delivery.
4. Novel tools, methodologies to understand and quantify cell uptake and the fate of the multiple components in drug delivery systems.
5. Tools/basic understanding on the role of the protein corona on the fate of the particles beyond the very general basic level

Ideally, computational work should be experimentally validated wherever possible. For articles to be accepted into the collection, the applications and relevance to chemical biology must be clear.

Authors are welcome to submit original research in the form of a Communication or Full Paper. The manuscript should be prepared according to our article guidelines and submitted via the respective journal’s website, . Information on the journals' scopes can be found at the bottom of this page.

All manuscripts will be subject to the usual initial assessment and peer review processes as necessary, and inclusion in the Collection will be at the discretion of the Guest Editors. Please indicate in your submission that you are submitting to this Collection and inform the Editorial Office by email.

Following our peer-review process, we will publish accepted articles online in a citeable form as soon as they are ready, with compilation and promotion of the complete collection in mid-2025.

About RSC Chemical Biology

Led by Hiroaki Suga (University of Tokyo), RSC Chemical Biology is dedicated to publishing and disseminating the most exceptionally significant, breakthrough findings of interest to the chemical biology community. All submissions are handled by our experienced and internationally recognised Associate Editors. For more information on the journal, please visit the .

About RSC Pharmaceutics

RSC Pharmaceutics acknowledges how chemistry and related disciplines can make a big difference to addressing health challenges. The journal provides a platform to publish crucial research on pharmaceutics, covering emerging technologies and techniques in pharmaceutics, including drug delivery, precision medicine, and enhanced drug targeting. Publications in RSC Pharmaceutics have the potential to drive real change in worldwide health. For more information on the journal, please visit the journal page.

As gold open access journals, there are no barriers to accessing content and your research article will reach an international audience. Article processing charges apply at RSC Chemical Biology – please see the journal page for details on fees, discounts, and waivers.

What would you like to know about RSC Pharmaceutics?